Evidence map›Paper›PMID 41648079›Full record

ArticleOpen forum infectious diseases2026

Risk Factors for Community Colonization With Extended-Spectrum Cephalosporin-Resistant Enterobacterales Among People Living With HIV in Botswana.

Bogadi Loabile, Ebbing Lautenbach, Naledi Mannathoko, Mosepele Mosepele, Ashley Styczynski, Rachel M Smith, Leigh Cressman, Anne Jaskowiak-Barr, Warren B Bilker, Kevin Alby and 8 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Bogadi LoabileDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-0636-8047
Ebbing LautenbachDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0003-4772-2409
Naledi MannathokoDepartment of Biomedical Sciences, University of Botswana, Gaborone, Botswana.ORCID https://orcid.org/0000-0002-9429-2838
Mosepele MosepeleDepartment of Internal Medicine, University of Botswana, Gaborone, Botswana.
Ashley StyczynskiDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-4682-8087
Rachel M SmithDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Leigh CressmanCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Anne Jaskowiak-BarrCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Warren B BilkerDepartment of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kevin AlbyDepartment of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.
Laurel GlaserDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Melissa Richard-GreenblattDepartment of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0001-6717-8856
Laura CowdenCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0002-6469-9271
Kgotlaetsile SewawaBotswana-University of Pennsylvania Partnership (BUP), Perelman School of Medicine, University of Pennsylvania, Gaborone, Botswana.
Dimpho OtukileBotswana-University of Pennsylvania Partnership (BUP), Perelman School of Medicine, University of Pennsylvania, Gaborone, Botswana.
Giacomo M PaganottiDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-0751-0682
Margaret MokomaneDepartment of Biomedical Sciences, University of Botswana, Gaborone, Botswana.ORCID https://orcid.org/0000-0002-4406-3594
Robert GrossDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: People living with HIV (PLWH) make up a significant proportion of the population in sub-Saharan Africa, and there exists a significant gap in research on the burden and associated risk factors for extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in this population. We describe the risk factors associated with ESCrE colonization in nonhospitalized PLWH. Methods: This is a secondary data analysis of nonhospitalized adult PLWH included in a regional surveillance cohort study describing colonization with ESCrE in Botswana. Participants underwent rectal swab sampling to identify ESCrE. Bivariate and multivariable analysis was used to determine risk factors associated with ESCrE colonization. Results: A total of 546 adult PLWH were recruited over 3 districts and were included in this analysis. The mean (standard deviation) age was 42 (10.4) years, and 448 (82.1%) were women. Our findings demonstrated that 27.3% (149/546) of participants screened positive for ESCrE rectal colonization. Independent risk factors {adjusted odds ratio (aOR) [95% CI]} for ESCrE colonization included recent hospitalization (3.37 [1.13-9.98]), at least 1 household member with ESCrE colonization (1.74 [1.01-3.00]), and recruitment before the countrywide COVID-19 lockdown (2.01 [1.33-3.04]). Recent antibiotic use had an elevated OR for ESCrE colonization that did not achieve statistical significance in the adjusted analysis (aOR: 1.84 [.92-3.68]). Conclusions: Hospitalization and colonization of other household members with ESCrE are important factors associated with colonization with ESCrE, as seen in other populations. The prevalence of ESCrE following the COVID-19 lockdown was significantly lower, suggesting the presence of factors that were protective against colonization. It is unclear how long these effects lasted.

Indexed as

Antibiotic resistancecolonizationEnterobacteralesextended-spectrum cephalosporinsHIV

Identifiers

PMID41648079
PMCPMC12871432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.